Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea

NCT02393937 is registered in ClinicalTrials.gov with bioRASI, LLC as lead sponsor.

NCT NCT02393937
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02393937 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Lead sponsor
bioRASI, LLC
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2015
Completion date
October 31, 2015
Enrollment
963 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

erythematotelangiectatic rosacea, papulopustular rosacea